The Utility of Pre- and Post-Transplant Oral Glucose Tolerance Tests: Identifying Kidney Transplant Recipients With or at Risk of New Onset Diabetes After Transplant
Open Access
- 17 March 2022
- journal article
- research article
- Published by Frontiers Media SA in Transplant International
- Vol. 35, 10078
Abstract
Background: New onset diabetes after transplant (NODAT) is common in kidney transplant recipients (KTRs). Identifying patients at risk prior to transplant may enable strategies to mitigate NODAT, with a pre-transplant oral glucose tolerance test (OGTT) suggested by the KDIGO 2020 Guidelines for this purpose. Methods: We investigated the utility of pre- and post-transplant OGTTs to stratify risk and diagnose NODAT in a retrospective, single-centre cohort study of all non-diabetic KTRs transplanted between 2003 and 2018. Results: We identified 597 KTRs who performed a pre-transplant OGTT, of which 441 had their post-transplant glycaemic status determined by a clinical diagnosis of NODAT or OGTT. Pre-transplant dysglycaemia was identified in 28% of KTRs and was associated with increasing age (p < 0.001), BMI (p = 0.03), and peritoneal dialysis (p < 0.001). Post-transplant dysglycaemia was common with NODAT and impaired glucose tolerance (IGT) occurring in 143 (32%) and 121 (27%) patients, respectively. Pre-transplant IGT was strongly associated with NODAT development (OR 3.8, p < 0.001). Conclusion: A pre-transplant OGTT identified candidates at increased risk of post-transplant dysglycaemia and NODAT, as diagnosed by an OGTT. Robust prospective trials are needed to determine whether various interventions can reduce post-transplant risk for candidates with an abnormal pre-transplant OGTT.Keywords
This publication has 44 references indexed in Scilit:
- Incidence and Risk Factors of Glucose Metabolism Disorders in Kidney Transplant Recipients: Role of Systematic Screening by Oral Glucose Tolerance TestTransplantation, 2011
- The association of early post-transplant glucose levels with long-term mortalityDiabetologia, 2011
- The shape of plasma glucose concentration curve during OGTT predicts future risk of type 2 diabetesDiabetes/Metabolism Research and Reviews, 2010
- New-Onset Diabetes Mellitus after Kidney Transplantation in DenmarkClinical Journal of the American Society of Nephrology, 2010
- New-onset diabetes after transplantation in tacrolimus-treated, living kidney transplantation: long-term impact and utility of the pre-transplant OGTTInternational Urology and Nephrology, 2010
- Impact of Acute Rejection and New-Onset Diabetes on Long-Term Transplant Graft and Patient SurvivalClinical Journal of the American Society of Nephrology, 2008
- Immunosuppressive medications, clinical and metabolic parameters in new-onset diabetes mellitus after kidney transplantationTransplant International, 2008
- Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine Versus TacrolimusAmerican Journal of Transplantation, 2007
- The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac eventsKidney International, 2006
- Development of Diabetes Mellitus Following Kidney Transplantation: A Canadian ExperienceAmerican Journal of Transplantation, 2004